Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 19270108)


Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.

Vickers AJ, Elkin EB, Peele PB, Dickler M, Siminoff LA.

Med Decis Making. 2009 Jul-Aug;29(4):461-7. doi: 10.1177/0272989X08329344. Epub 2009 Mar 6.


Forgone but not forgotten: the effects of partial and full feedback in "harsh" and "kind" environments.

Rakow T, Newell BR, Wright L.

Psychon Bull Rev. 2015 May 9. [Epub ahead of print]


Decision aids for people facing health treatment or screening decisions.

Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Thomson R, Trevena L, Wu JH.

Cochrane Database Syst Rev. 2014 Jan 28;1:CD001431. doi: 10.1002/14651858.CD001431.pub4. Review.


Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies.

Pinto AC, Ades F, de Azambuja E, Piccart-Gebhart M.

Breast. 2013 Aug;22 Suppl 2:S152-5. doi: 10.1016/j.breast.2013.07.029. Review.


Cost-effectiveness of the 21-gene assay for guiding adjuvant chemotherapy decisions in early breast cancer.

Paulden M, Franek J, Pham B, Bedard PL, Trudeau M, Krahn M.

Value Health. 2013 Jul-Aug;16(5):729-39. doi: 10.1016/j.jval.2013.03.1625. Epub 2013 Jul 1.


Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.

Feldman-Stewart D, Madarnas Y, Mates M, Tong C, Grunfeld E, Verma S, Carolan H, Brundage M.

Breast. 2013 Oct;22(5):919-25. doi: 10.1016/j.breast.2013.04.020. Epub 2013 May 28.


Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.

Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P.

J Clin Oncol. 2013 Jun 20;31(18):2249-56. doi: 10.1200/JCO.2012.44.5015. Epub 2013 Apr 22.


The effect of narrative information in a publicly available patient decision aid for early-stage breast cancer.

Shaffer VA, Tomek S, Hulsey L.

Health Commun. 2014;29(1):64-73. doi: 10.1080/10410236.2012.717341. Epub 2013 Feb 5.


Breast cancer treatment decision-making: are we asking too much of patients?

Livaudais JC, Franco R, Fei K, Bickell NA.

J Gen Intern Med. 2013 May;28(5):630-6. doi: 10.1007/s11606-012-2274-3. Epub 2012 Nov 15.


Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study.

Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL.

J Clin Oncol. 2012 Nov 1;30(31):3800-9. doi: 10.1200/JCO.2012.43.8168. Epub 2012 Sep 24.


Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.

Yao-Lung K, Dar-Ren C, Tsai-Wang C.

BMC Med Inform Decis Mak. 2012 Sep 17;12:108. doi: 10.1186/1472-6947-12-108.


Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.

Blohmer JU, Rezai M, Kümmel S, Kühn T, Warm M, Friedrichs K, Benkow A, Valentine WJ, Eiermann W.

J Med Econ. 2013;16(1):30-40. doi: 10.3111/13696998.2012.722572. Epub 2012 Sep 11.


Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy.

Wong J, D'Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H, Warner E, Franssen E, Szumacher E.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):30-8. doi: 10.1016/j.ijrobp.2011.11.028. Epub 2012 Feb 11.


Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.

Sail KR, Franzini L, Lairson DR, Du XL.

Value Health. 2012 Jan;15(1):72-80. doi: 10.1016/j.jval.2011.10.004.


High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial.

Fontein DB, Nortier JW, Liefers GJ, Putter H, Meershoek-Klein Kranenbarg E, van den Bosch J, Maartense E, Rutgers EJ, van de Velde CJ.

Eur J Surg Oncol. 2012 Feb;38(2):110-7. doi: 10.1016/j.ejso.2011.11.010. Epub 2011 Dec 14.


Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG).

Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20.


Decision aids for people facing health treatment or screening decisions.

Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD001431. doi: 10.1002/14651858.CD001431.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD001431.


Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

Bedognetti D, Sertoli MR, Pronzato P, Del Mastro L, Venturini M, Taveggia P, Zanardi E, Siffredi G, Pastorino S, Queirolo P, Gardin G, Wang E, Monzeglio C, Boccardo F, Bruzzi P.

J Natl Cancer Inst. 2011 Oct 19;103(20):1529-39. doi: 10.1093/jnci/djr351. Epub 2011 Sep 15.


Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer.

Truin W, Voogd AC, Vreugdenhil G, van der Sangen MJ, van Beek MW, Roumen RM.

Breast. 2011 Dec;20(6):505-9. doi: 10.1016/j.breast.2011.05.005. Epub 2011 Jun 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk